Company Overview - ImmuCell Corporation is an animal health company focused on developing, manufacturing, and marketing products that enhance the health and productivity of dairy and beef cattle [5] - The company is known for its product First Defense®, which provides Immediate Immunity™ to newborn dairy and beef calves, and is developing Re-Tain®, a treatment for subclinical mastitis in dairy cows [5] Financial Reporting - ImmuCell expects to report unaudited financial results for the quarter and year ended December 31, 2024, after the market closes on February 25, 2025 [1] - The company anticipates no change to the preliminary sales results for the fourth quarter and year ended December 31, 2024, which were disclosed on January 9, 2025 [3] - An Annual Report on Form 10-K is expected to be filed on or before March 31, 2025 [3] Conference Call - A conference call to review the unaudited financial results is scheduled for February 26, 2025, at 9:00 AM ET [2] - Interested parties can access the call via specific toll-free and international numbers, with a replay available until March 5, 2025 [2] Investor Relations - Investors are encouraged to review the updated Corporate Presentation slide deck available on the company's website, which provides an overview of the business [4] - An updated version of the slide deck will be made available after the market closes on February 25, 2025 [4]
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024